Outcome, efficacy and safety of endovascular thrombectomy in ischaemic stroke according to time to reperfusion: data from a multicentre registry

Other authors

Institut Català de la Salut

[Meinel TR, Jung S, Arnold M] Department of Neurology, University Hospital Bern, Inselspital, Bern, Switzerland. University of Bern, Bern, Switzerland. [Kaesmacher J] Institute of Diagnostic and Interventional Neuroradiology, Institute of Diagnostic, Interventional and Pediatric Radiology and Department of Neurology, University Hospital Bern, Inselspital, Bern, Switzerland. University of Bern, Bern, Switzerland. [Mordasini P, Mosimann PJ] University Institute of Diagnostic and Interventional Neuroradiology, University Hospital Bern, Inselspital, Bern, Switzerland. University of Bern, Bern, Switzerland. [Ribo M, Requena M] Servei de Neurologia, Hospital Universitari Vall d'Hebron, Barcelona, Spain.

Vall d'Hebron Barcelona Hospital Campus

Publication date

2019-06-14T12:11:56Z

2019-06-14T12:11:56Z

2019-03-27

Abstract

Endovascular; Mechanical thrombectomy; Stroke


Endovascular; Trombectomia mecànica; Accident cerebrovascular


Endovascular; Trombectomía mecánica; Accidente cerebrovascular


BACKGROUND AND PURPOSE: In acute ischaemic stroke (AIS) of the anterior circulation (AC) treated with mechanical thrombectomy (MT), data point to a decline of treatment effect with increasing time from symptom onset to treatment. However, the magnitude of the decline will depend on the clinical setting and imaging selection used. The aims of this study were (1) to evaluate the clinical effect of time to reperfusion (TTR); and (2) to assess the safety and technical efficacy of MT according to strata of TTR. METHODS: Using the retrospective multicentre BEYOND-SWIFT registry data (ClinicalTrials.gov identifier: NCT03496064), we compared safety and efficacy of MT in 1461 patients between TTR strata of 0-180 min (n = 192), 180-360 min (n = 876) and >360 min (n = 393). Clinical effect of TTR was evaluated using multivariable logistic regression analyses adjusting for pre-specified confounders [adjusted odds ratios (aOR) and 95% confidence intervals (95% CI)]. Primary outcome was good functional outcome (modified Rankin Scale: mRS 0-2) at day 90. RESULTS: Every hour delay in TTR was a significant factor related to mRS 0-2 (aOR 0.933, 95% CI 0.887-0.981) with an estimated 1.5% decreased probability of good functional outcome per hour delay of reperfusion, and mRS 0-1 (aOR 0.929, 95% CI 0.877-0.985). Patients with late TTR had lower rates of successful and excellent reperfusion, higher complication rates and number of passes. CONCLUSIONS: TTR is an independent factor related to long-term functional outcome. With increasing TTR, interventional procedures become technically less effective. Efforts should be made to shorten TTR through optimized prehospital and in-hospital pathways.

Document Type

Article


Published version

Language

English

Publisher

SAGE Publications

Related items

Therapeutic Advances in Neurological Disorders;12

https://journals.sagepub.com/doi/10.1177/1756286419835708

Recommended citation

This citation was generated automatically.

Rights

Attribution-NonCommercial-NoDerivatives 4.0 International

http://creativecommons.org/licenses/by-nc-nd/4.0/

This item appears in the following Collection(s)